chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore throat; The rash has spread to her stomach, arms and face; She "thought she might be having an allergic reaction"; She has "redness and swelling at the injection site, along with several bumps around the area"; She has "redness and swelling at the injection site, along with several bumps around the area"; along with several bumps around the area"; This spontaneous report has been received from a registered nurse referring to a 49 year old female patient. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.   On 10-JUN-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # R031628 with expiration date of 01-NOV-2020, 1 dosage form, subcutaneously (strength, frequency, dose, and anatomical location were not provided). for measles, mumps, rubella protection.         On 24-JUN-2019, the patient thought she might be having an allergic reaction (hypersensitivity), she presented redness and swelling at the injection site (infusion site swelling and injection site erythema), along with several bumps around the area (skin disorder). The patient received "anthistamine and ibuprofen" to relieve the symptoms.  On 26-JUN-2019, the patient's symptoms were worsening, since she experienced sore throat (oropharyngeal pain) and the rash had spread to her stomach, arms and face (rash generalised). The patient sought medical attention. At the reporting time, the outcome of hypersensitivity, rash generalised, oropharyngeal pain, skin disorder, infusion site swelling and injection site erythema was reported as not resolved. The causality assessment was not provided.  This is one of two cases from the same reporter.; Sender's Comments:  US-009507513-1906USA011145:
This spontaneous report as received from a physician refers to an unspecified number of patients. On unknown dates an unspecified number of patients were administered with doses of VAQTA (lot#, strength, dose, frequency, route unknown) that were improperly stored. No adverse effects were reported. The outcome of the event was unknown. This is one of several reports received from the same source. Additional information has been requested.
Numbness in the left pinky finger 15 minutes after the shot which went away by movement of the arm. developed numbness in the right foot. Numbness is getting better day by day.
This is an instance of breakthrough COVID-19 after which death occurred. The individual also died 6 days after receipt of third dose of the Moderna product. The positive test occurred after receipt of second dose but before the third.   The individual was vaccinated with the Moderna product on 01/07/2021, 02/04/2021, and 11/01/2021. They tested positive for COVID-19 on 10/15/2021 at the assisted living facility at which they were a resident. They were hospitalized related to this illness 10/17/2021-10/20/2021 in an out-of-state hospital.  They experienced complications of COVID-19 pneumonia. They died on 11/06/2021.
Right sided hemibody numbness - arm and flank and hip and right leg.  Severe dizziness continous balance problem - sways sideways when walking.  Visual difficulty while reading, cannot read any more.  Right shoulder and shoulderblade feel like a block.  Right ear tinnitus but feels thoughout the head, intermittent.
Information has been received from a consumer, who is the uncle of the approximately 24 months old male patient with no previous medical history who reported sometime in 2006 was vaccinated with a single dose of series of MMR II. Almost two weeks after receiving the MMR II in 2006, the patient was inconsolable and cried non stop. Then after the two weeks the patient did not act the same and was quiet and reserved. The consumer reported that the patient saw different physicians and took vitamin B (manufacturer unspecified) shots that helped the patient the most. As of 18-FEB-2009, the patient's adverse events persisted. No further information is available.
This case was reported by a consumer via call center representative and described the occurrence of protein total increased in a 67-year-old female patient who received SHINGRIX for prophylaxis. On 6th September 2018, the patient received the 1st dose of SHINGRIX. On 7th September 2018, 1 days after receiving SHINGRIX, the patient experienced nausea. On 18th September 2018, the patient experienced protein total increased. On an unknown date, the outcome of the protein total increased was unknown and the outcome of the nausea was recovered/resolved. It was unknown if the reporter considered the protein total increased and nausea to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on the right arm. The patient reported feeling slightly nauseous when she woke the next morning which was very mild. On 18th September 2018, she had laboratory work done with a slight increase in her IGA protein (blood immunoglobulin A).
Patient received a 3rd dose of the Shingrix vaccine. Prior two doses administered in 2019. patient was not experiencing any side effects.
This spontaneous report as received from an unspecified provider at a conference via a company representative, refers to a 70 year old patient of unknown gender. No pertinent medical history or drug reactions/allergies were provided. The reporter stated that on an unknown date the patient was administered ZOSTAVAX VIAL (dose, route and lot number not provided), and was diagnosed with shingles (date unspecified). At the time of the report, the outcome of the event was unknown. Additional information is not expected because the reporter details were not provided.
I started to feel periods of confusion shortly after the first dose and continue to feel short periods of confusion. My second dose is scheduled for May 8, 2021.
body shocks; Vaccine exposure during pregnancy; face feels tight; flushed; body ache; fever of 103.0; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of SHOCK (body shocks) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pregnancy (Live full-term birth) on 20-Apr-2018. Concurrent medical conditions included Drug allergy.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 13-Mar-2021 and the estimated date of delivery was 18-Dec-2021. On an unknown date, the patient experienced SHOCK (body shocks) (seriousness criterion medically significant), EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), REDUCED FACIAL EXPRESSION (face feels tight), FLUSHING (flushed), MYALGIA (body ache) and PYREXIA (fever of 103.0). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy.  At the time of the report, SHOCK (body shocks), EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), REDUCED FACIAL EXPRESSION (face feels tight), FLUSHING (flushed), MYALGIA (body ache) and PYREXIA (fever of 103.0) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided  Company comment: This case of a 25-year-old, P1G2 female with who experienced Vaccine exposure during pregnancy.  Last menstrual period was 13-Mar-2021 and estimated date of delivery was 18-Dec-2021. Based on a temporal association between the use of mRNA-1273 vaccine and onset of the other reported events, a causal relationship cannot be excluded. Myalgia and fever are consistent with product safety profile.  Vaccine exposure du7ring pregnancy is assessed as not applicable.; Sender's Comments: This case of a 25-year-old, P1G2 female with who experienced Vaccine exposure during pregnancy.  Last menstrual period was 13-Mar-2021 and estimated date of delivery was 18-Dec-2021. Based on a temporal association between the use of mRNA-1273 vaccine and onset of the other reported events, a causal relationship cannot be excluded. Myalgia and fever are consistent with product safety profile.  Vaccine exposure du7ring pregnancy is assessed as not applicable.
Deep muscle pain, redness: enough to look like a start of an abcess.  Manufacturer: Aventis Pasteur.  I have previously c/o simular reactions to my TB skin test and have been told "it's nothing to worry about."  The redness has increased each year from it.  So this year I was offered an alternate "preservative" and still had a reaction.  The answer they gave my was that I was not going to have anaphlaxis.  I did not say I thought it was going to happen-I just don't want to be treated for TB because I am allergic to the preservative.
Information has been received from a physician concerning a 20 week old patient who on 29-AUG-2011 was vaccinated with the first dose of ROTATEQ (lot # not provided). The physician refused to provide any specific patient data. No adverse effects reported. Additional information has been requested. This is a an amended report. The reporting status was changed from do not send to periodic.
Venous dilation/varicosities in bilateral lower extremities with associated mild bilateral lower extremity edema and paresthesias.
Left arm became extremely painful and swelled up; Pain moved up to the shoulder and my arm was sensitive and very hot to the touch. I could not raise my left arm above my left shoulder for at least  day and a half. Went back to the clinic where I had received the shots and was told that that could happen. After some discussion, I was given a handout on each shot that had been given. Right arm was fine and not a problem.
Got booster phizer now experience stiff and. Numb face tingling in both hands arms Got covid booster noticed tingling and stiff face 2 days later
pt recv vax 6SEP97 &  c/o hives, trouble w/school work, hives pain;low grade fever, nausea, lightheadedness,
Pain in right jaw as toothache for six days. Diagnoses was infection of Salva gland.  Prescription of AMOX-CLAV 875-125MG tablets. Issue resolved in two days.
Extreme lethargy ,felt like the flu I have not been sick in 35 years and this booster kicked my butt for 2 days,,
first Covid shot January 27,2021, second Covid shot February 17, 2021,  first Covid booster August 27, 2021. After the first booster, (#3), I developed a gray spot in my right eye and a neon glow,  that was on September 8, 2021. On September 10, 2021, I went to the eye doctor he sent me in for a blood test after the blood test,  The doctor diagnosed me with non-arthritic . ischemic  optic neuropathy in my right eye, causing me to lose 3/4 of the vision in my right.The  eye doctor sent me in for an MRI on November 10, 2021 to confirm. There is nothing that can be done. Second Covid booster July 20, 2022.. I strongly feel the covid shots caused my vision loss. I hope and pray that it does not take my left eye also.
Vitamin D deficiency; Fatigue; Chills; On and off nausea that lasts an hour and a half; This spontaneous case was reported by a consumer and describes the occurrence of VITAMIN D DEFICIENCY (Vitamin D deficiency), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (On and off nausea that lasts an hour and a half) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Mitral valve replacement and Pacemaker insertion (cardiac). Concurrent medical conditions included Migraine and Asthma. Concomitant products included METOPROLOL, ESCITALOPRAM OXALATE (LEXAPRO), TOPIRAMATE (TOPAMAX), CYCLOBENZAPRINE and OMEPRAZOLE for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (On and off nausea that lasts an hour and a half). On 14-Apr-2021, the patient experienced VITAMIN D DEFICIENCY (Vitamin D deficiency). The patient was treated with CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for Vitamin D deficiency, at a dose of UNK, qd and VITAMIN D [VITAMIN D NOS] for Vitamin D deficiency, at a dose of 50000 unit once a week. On 31-Mar-2021, NAUSEA (On and off nausea that lasts an hour and a half) had resolved. At the time of the report, VITAMIN D DEFICIENCY (Vitamin D deficiency), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.            Expiry date of vaccine was given as 1 JAN 1900  Action taken with mRNA-1273 in response to the events was not applicable.
27th January 2021-Stuttered, right eye drooping-in the ER-patient is and employee of the staff. The providers in the ER did a quick neuro check/test-27th January 2021. Outcome-she can smile, can blink and has no stutter today 4 February 2021
Pt's mother reported that pt had red, raised areas about the size of mosquito bites on bilateral anterior thighs extending to groin area that were noted about 1 hour post vax and increased in size since. The areas were itching per patient.
This spontaneous report was received from a family nurse practitioner, and refers to a 10 month old patient of unknown gender. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On 19-SEP-2016 , the patient was inadvertently vaccinated with an adult dose of RECOMBIVAX HB intramuscularly, lot # M001579 with expiration date 05-OCT-2018 (dose and frequency were not reported). No concomitant medications, adverse effects or product quality complaints were reported. Additional information has been requested.
Tingling feeling in arm where injection site is located, numbness and pain in arm. Currently going on 6 weeks.
approx 1mo p/vax pt devel 6 pustules on scalp & forehead
Whole body muscle aches and pains, chills, fever between 100- 101.  These symptoms began within about 14 hours after the shot and lasted for about 15 hours.  Then just tired for several hours
Death  11/27/07 Reviewed vax record which confirms dose & lot #s as reported. 4/15/08 Autopsy report states COD as anoxic/hypoxic encephalopathy & bronchopneumonia due to infantile reflux & aspiration while sleeping.
On 01/14/2001 the child developed a rash, described as huge raised welts. The rash was blotchy and itchy. The rash spread to the patient's chest, back, anus and ankles. The physician described the rash as erythema multiform. The child was given Benadryl and Aveeno Baths. The child was sleeping a lot, had no fever, and no respiratory problems. No further details were provided. Additional information has been requested.
Hives appeared 7 hours after vaccine. Hives have continued to show up on my body lasting 15 min. to an hour before they disappear. They appear all over my body and continue  to this date (2/4/21).
Pt received Dtap and IPV at 5yr well visit. Both given in same arm. Pt developed red, hot, swollen upper arm. Rx for 3-5 days. Rx'ed with cool compress, BENADRYL and MOTRIN. Pt recovers. Pt had similar reaction to FLUZONE past 2 yrs.
no adverse event; administered an impropery stored dose of PEDVAX HIB; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. Patient's pertinent medical history, concurrent conditions, past drugs, allergies and concomitant therapies were not reported. On 20-APR-2020, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, dose and route were not reported) (lot number S023645 and expiration date 10-MAR-2022) for prophylaxis (product storage error). The temperature excursion was noted with a temperature of 51.5 Fahrenheit (F) for 45 minutes. There was no previous temperature excursion. No adverse effects were reported. The call was because of digital data logger. No product quality complaint was reported.  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-2005USA002553:
watery eyes; runny nose; This is a spontaneous report from a contactable consumer.   A 78-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2) at single dose on 30Jan2021 for COVID-19 immunisation, administered at hospital.  The patient medical and concomitant medications were not reported. The patient previously received the 1st dose of bnt162b2 (BNT162B2) on 04Jan2021 (also reported as 07Jan2021) for COVID-19 immunisation, administered at hospital and the reporter did not indicate that he had any side effects.  The patient experienced watery eyes and runny nose in 2021. He did not experience any headache. No treatment was received. No admission to hospital due to the events. The outcome of events was recovered in 2021, he was fine now.    Information about lot/batch number has been requested.
The muscle where I I got the shot hurt but went away. In July it felt like it does when you touch something and get zapped by static electricity. Then the muscles in neck and arm would hurt when I moved certain ways. It went from occasional pain in the muscle to a more dull constant pain in my left shoulder, neck and upper back. In October, the pain progressed to the point that I went to see my PCP. He ordered X-rays and sent me for Physical therapy. In November my PCP sent me to an Orthopedist who discovered that I have calcification in my left shoulder. I have had cortisone shots that have helped alleviate that pain for some months but now the shots have worn off and the dull ache is back and I have a hard time sleeping.
10 days after the MMR vaccine, pt had a fever between 103-105 for 5 consecutive days.  On day 2, he started having myoclonic jerks that persisted for about 36 hours.  These myoclonic jerks have since occurred every time he has a fever.  He is almost 3 years old.  He is treated with Ativan while febrile.
This spontaneous report as received from a other health professional refers to an unspecified number of patients of unknown age and gender. On 02-JUN-2017, 05-JUN-2017 and 06-JUN-2017, the patient were vaccinated with an improperly stored dose of GARDASIL 9 lot # M041212, 1 DF for prophylaxis.  No averse effects were reported.
2/6/19 C/O head congestion. 2/7 started with low grade temp. MOTRIN/TYLENOL/HALLS lozenges/ MUCINEX, 2/7/19 8:31 temp of 102.2, 2/8/19 nasal congestion & cough, Temp 102.9, Diagnosed with UTI, MACROBID started. Low sodium, IV fluids (NS) started and CXR done (no acute cardiopulmonary disease), 2/9 R deltoid skin infection, redness, tender, 10-15 cm in diameter, site of pneumonia vaccine on 2/6/19. WBC increased, MACROBID discontinued, KEFLEX & BACTRIM started to cover both UTI and skin infection.  Infection continued to improve until 2/16/19 when it was completely resolved.
excruciating joint pain/ had arthritic pain, on thumb, like he broke his thumb then went to toes on left side, it was his whole body, both elbows/ pain in his shoulder; can't lift my left arm for 4 days (injection arm); pain in the joints, even up in jaw bone/ It hurt so bad couldn't eat soup; had a hard time getting around with oxygen.; This is a spontaneous report from a contactable consumer (Patient). A 65-year-old male patient received a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in left arm on 14Jan2021 (Lot Number: EK9231) as single dose for prevention. Medical history included pulmonary fibrosis and dyslexia. There were no concomitant medications. Patient reported "excruciating joint pain after receiving 1st dose Pfizer vaccine. Second dose was scheduled for 04Feb2021. Patient stated that three days after receiving the first dose he had arthritic pain, on thumb - like he broke his thumb (he put on aspercreme and took Advil) but night it went away. The next day my left foot (he put on aspercreme and took Advil), then moved up to his right wrist. same thing. excruciating joint pain and it would move around, it started on his thumb one his right side, then went to toes on left side, it was his whole body, both elbows, now he can't lift his left arm (injection arm) for 4 days. There is pain in his shoulder, he can move his shoulder, but to do the chicken wing with his arm, he cannot do it. Got the shot on 14Jan2021, this started 3 days later. To switch positions, from his toes to his knee joints, and it is both sides of his body. His little joints are there one day and gone, he puts Aspercreme on and took Advil, and by night time the pain was gone, but the next day it was somewhere else. The smaller joints, like in his toes and knuckles on his hands, lasted one day, but his knees, bigger joints, was 2 days, his wrists were a day, it even went up to his jawbone, he couldn't suck soup, so it's pretty bad when you can't drink soup. His left arm had been going on for 4 days. He went to his rheumatologist, and the doctor he took 9 vials of blood, because caller's next shot is supposed to be on 04Feb2021, and he was up in the air about getting it with all the pain going on, so the doctor took a look, did 9 vials of blood, and said right now he would not advise getting it until he looked at the bloodwork to see if there was compatible, and the doctor said he would be in touch by the 4thFeb2021. Patient stated he was dyslexic. He also stated he had a hard time getting around with oxygen. Patient stated that he sees a lung specialist for the last 5 years, he has pulmonary fibrosis. Seriousness of the event was reported as non-serious. The patient underwent lab test that includes bloodwork: unknown results on an unspecified date. Outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a 4-year-old who was vaccinated on an unspecified date with a dose of varicella virus vaccine live (Oka/Merck). Immediately, the patient developed facial red spots. Benadryl was given and the patient was stabilized. No other information was available. This event not occur at the reporting physicians office. This is one of several reports from the same reporter. Additional information has been requested.
This spontaneous report was received from a health care professional refers to multiple unspecified patients of unknown demographics. On an unknown dates the patients were vaccinated with improperly stored PNEUMOVAX 23 injection (dosing regimen unspecified) (lot # L003227, expiry 13-OCT-2016). Excursion details are as follows: which were exposed to the following conditions, were administered to unspecified patients: temperature: 31.55 F, Time frame: 45 seconds, there was no previous temperature excursion. It was a call because of a data logger. No adverse effect reported. No further information was provided. This is one of the several reports from the same reporter. Additional information has been requested.